Literature DB >> 17586863

Is gout associated with reduced quality of life? A case-control study.

E Roddy1, W Zhang, M Doherty.   

Abstract

OBJECTIVES: To compare quality of life (QOL) between gout cases and controls in a primary care population and to investigate whether impaired QOL in gout is secondary to co-morbid factors or to intrinsic factors related to gout itself.
METHODS: A postal questionnaire was sent to all adults aged over 30 yrs registered with two general practices. The questionnaire assessed a history of gout (doctor diagnosed, or episodes suggestive of acute crystal synovitis) and medical and musculoskeletal co-morbidities. QOL was assessed using the WHOQoL-Bref instrument. Possible cases of gout attended for clinical assessment where the diagnosis was verified on clinical grounds. Overall QOL, satisfaction with health and QOL across four domains were compared between gout cases and controls and then entered into a linear regression model adjusting for gout, age, gender, body mass index and medical and musculoskeletal co-morbidities.
RESULTS: Of 13 684 questionnaires mailed, 3082 completed questionnaires were returned (23%). From 289 suggested cases of gout, 137 cases were confirmed by clinical assessment. Compared with controls, cases had impaired overall QOL (15.67 vs 16.41, P = 0.003), satisfaction with health (13.16 vs 14.45, P < 0.001) and physical health-related QOL (14.08 vs 15.95, P < 0.001). On multi-variate analysis, gout remained associated with impaired physical health-related QOL (beta = -0.059, P = 0.001) but not overall QOL (beta = -0.024, P = 0.198) or satisfaction with health (beta = -0.028, P = 0.142).
CONCLUSIONS: Gout associates with poor overall QOL mainly resulting from associated co-morbidity. Physical health-related QOL, however, remains impaired after adjustment for co-morbidities.

Entities:  

Mesh:

Year:  2007        PMID: 17586863     DOI: 10.1093/rheumatology/kem150

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  54 in total

Review 1.  Risk factors for gout and prevention: a systematic review of the literature.

Authors:  Jasvinder A Singh; Supriya G Reddy; Joseph Kundukulam
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

2.  [European League Against Rheumatism evidence-based recommendations for diagnosis and management of gout].

Authors:  B Grusch; B Rintelen; B F Leeb
Journal:  Z Rheumatol       Date:  2007-11       Impact factor: 1.372

Review 3.  Difficult-to-treat gouty arthritis: a disease warranting better management.

Authors:  Naomi Schlesinger
Journal:  Drugs       Date:  2011-07-30       Impact factor: 9.546

4.  The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012.

Authors:  Sharan K Rai; J Antonio Aviña-Zubieta; Natalie McCormick; Mary A De Vera; Kam Shojania; Eric C Sayre; Hyon K Choi
Journal:  Semin Arthritis Rheum       Date:  2016-08-17       Impact factor: 5.532

5.  The 3-Year Incidence of Gout in Elderly Patients with CKD.

Authors:  Vivian S Tan; Amit X Garg; Eric McArthur; Ngan N Lam; Manish M Sood; Kyla L Naylor
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-02       Impact factor: 8.237

Review 6.  Determinants of the prevalence of gout in the general population: a systematic review and meta-regression.

Authors:  José M A Wijnands; Wolfgang Viechtbauer; Kristof Thevissen; Ilja C W Arts; Pieter C Dagnelie; Coen D A Stehouwer; Sjef van der Linden; Annelies Boonen
Journal:  Eur J Epidemiol       Date:  2014-07-27       Impact factor: 8.082

7.  Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study.

Authors:  Janet W Maynard; Mara A McAdams-DeMarco; Andrew Law; Linda Kao; Allan C Gelber; Josef Coresh; Alan N Baer
Journal:  Am J Epidemiol       Date:  2013-12-13       Impact factor: 4.897

Review 8.  Quality of life and quality of care for patients with gout.

Authors:  Jasvinder A Singh
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

9.  Cost-effectiveness of febuxostat in chronic gout.

Authors:  Stephen M Beard; Birgitta G von Scheele; George Nuki; Isobel V Pearson
Journal:  Eur J Health Econ       Date:  2013-05-30

Review 10.  Racial and gender disparities among patients with gout.

Authors:  Jasvinder A Singh
Journal:  Curr Rheumatol Rep       Date:  2013-02       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.